Abstract
Ribozymes targeted to a point mutation (histidine for proline substitution at position 23) in rhodopsin were evaluated as therapeutic agents for photoreceptor degeneration in an animal model of autosomal dominant retinitis pigmentosa (ADRP). Recombinant adeno-associated virus (AAV) vectors incorporating a proximal bovine rod opsin promoter were used to transfer either hairpin or hammerhead ribozyme genes to photoreceptors. AAV was administered by subretinal injection at postnatal day (P) 15 to rats expressing a rod opsin transgene with a proline-to-histidine substitution in exon 1 at codon 23 of the rhodopsin gene (P23H). In vivo levels of normal and mutant RNAs were measured by allele-specific RT-PCR at P60. Eyes were examined by histopathology and morphometric analysis, as well as by ERG at approximately P60, P75 or P90. Expression of either a hammerhead or hairpin ribozyme markedly slowed the rate of photoreceptor degeneration for at least 3 months as determined by outer nuclear layer thickness as well as by inner and outer segment length. Catalytically inactive control ribozymes had a significantly smaller effect on the retinal degeneration. Minimal rescue effects were seen in retinas injected with either AAV containing a gene for green fluorescent protein rather than the ribozyme gene or buffer only. The level of mutant opsin RNA relative to wild-type RNA was also reproducibly lower in ribozyme-treated retina. Finally, ERG comparisons of ribozyme-treated versus control eyes demonstrated functional rescue. We conclude that ribozyme-directed cleavage of mutant mRNAs appears to be a potentially effective therapy for autosomal dominant retinal degeneration.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
P. Steinecke, T. Herget, and P.H. Schreier, 1992, Expression of a chimeric ribozyme gene results in endonucleolytic cleavage of target mRNA and a concomitant reduction of gene expression in vivo., EMBO. J. 11:1525–1530.
K.R. Birikh, P.A. Heaton, and F. Eckstein, 1997, The structure, function, and application of the hammerhead ribozyme., Eur. J. Biochem. 245:1–16.
J.J. Rossi, 1997, Therapeutic applications of catalytic antisense RNAs (ribozymes)., Ciba. Found. Symp. 209. 195–204.
ML Cotten and M.L. Birnstiel, 1989, Ribozyme mediated destruction of RNA in vivo., EMBO. J. 8:3861–3866.
A. Lieber, and M.A. Kay, 1996, Adenovirus-mediated expression of ribozymes in mice., J. Virol. 70:3153–3158.
P. L’Huillier, S. Soulier, and M.G. Stinnakre, et al., 1996, Efficient and specific ribozyme-mediated reduction of bovine alpha-lactalbumin expression in double transgenic mice., Proc. Natl. Acad. Sci. 93:6698–6703.
X. Xiao, J. Li, and R.J. Samulski, 1996, Efficient long-term transfer into muscle tissue of immuno-competent mice by adeno-associated virus vector., J. Virol. 70:8098–8108.
K.J. Fisher, K. Jooss, and J. Alston, et al., 1997, Recombinant adeno-associated virus for muscle directed gene therapy., Nat. Medicine. 3:306–312.
J.G. Flannery, S. Zolotukhin, M.I. Vaquero, M.M. LaVail, N. Muzyczka, and W.W. Hauswirth, 1997, Efficient photoreceptor-targeted gene expression in vivo by recombinant adeno-associated virus. Proceedings of the National Academy of Sciences of the United States of America. 94(13):6916–6921.
S. Zolotukhin, M. Potter, W.W. Hauswirth, J. Guy, and N. Muzyczka, 1996, A “humanized” green fluorescent protein cDNA adapted for high-level expression in mammalian cells., J. Virol. 70:4646–4654.
L.E. DesJardin and W.W. Hauswirth, 1996, Developmentally important DNA elements within the bovine opsin upstream region, Investigative Ophthalmology and Visual Science. 37(1):154–165.
K.A. Drenser, A.M. Timmers, W.W. Hauswirth, and A.S. Lewin, 1998, Ribozyme-targeted destruction of RNA associated with autosomal-dominant retinitis pigmentosa, Investigative Ophthalmology and Visual Science. 39(5):681–689.
M. Altschuler, R. Tritz, and A. Hampel, 1992, A method for generating transcripts with defined 5’ and 3’ termini by autolytic processing., Gene. 122:85–90 (1992).
E. Bertrand, D. Castanotto, and C. Zhou, et al., 1997, The expression cassette determines the functional activity of ribozymes in mammalian cells by controlling their intracellular localization., RNA. 3:75–88.
T.R. Flotte and B. Carter, 1995, Adeno-associated virus vectors for gene therapy., Gene Therapy. 2:357–362.
R.H. Steinberg, J.G. Flannery, M.I. Naash, J. Chen, M. Matthes, D. Yasumura, and M.M. LaVail, 1996, Transgenic rat models of inherited retinal degeneration caused by mutant opsin genes., Inv. Ophth. Vis. Sci. 37. S698.
M.M. LaVail and B.A. Battelle, 1975, Influence of eye pigmentation and light deprivation on inherited retinal dystrophy in the rat., Exp. Eye Res. 21:167–192.
E.G. Faktorovich, R.H. Steinberg, D. Yasumura, M.T. Matthes, and M.M. LaVail. 1990, Photoreceptor degeneration in inherited dystrophy delayed by the basic fibroblast growth factor., Nature. 347:83–86.
A.M. Timmers, B.R. Newton, and W.W. Hauswirth, 1993, Synthesis and stability of retinal photorecptor mRNAs are coordinately regulated during bovine fetal development., Exp. Eye Res. 56:251–265.
J.J. Michon, Z.L. Li, S.N. Zhioura, R.J. Anderson, and M.O. Tso, 1991, A comparative study of methods of photoreceptor morphometry., Invest. Ophthalmol. Vis. Sci. 32:280–284.
R. Wen, Y. Song, and T. Cheng, et al., 1995, Injury-induced upregulation of bFGF and CNTF mRNAS in the rat retina., J. Neumsci. 15:7377–7385.
R. Hormes, M. Homann, and I. Oelze, et al., 1997, The subcellular localization and length of hammerhead ribozymes determine efficacy in human cells., Nucleic. Acids. Res. 25:769–775.
A.S. Lewin, K.A. Drenser, W.W. Hauswirth, S. Nishikawa, D. Yasumura, J.G. Flannery, and M.M. LaVail, 1998, Ribozyme rescue of photoreceptor cells in a transgenic rat model of autosomal dominant retinitis pigmentosa, Nature Medicine. 4(8):967–71.
N. Mittereder, K.L. March, and B.C. Trapnell, 1996, Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy., J. Virol. 70:7498–7509.
C. Nyberg-Hoffman, P. Shabram, W. Li, D. Giroux, and E. Aguilar-Cordova, 1997, Sensitivity and reproducibility in adenoviral infectious titer determination., Nature Medicine. 3:808–811.
H. Miyoshi, M. Takahashi, F. Gage, and I. Verma, 1997, Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector, PNAS. 94:10319–10323.
S. Mohand-Said, D. Hicks, and M. Simonutti, et al., 1997, Photoreceptor transplants increase host cone survival in the retinal degeneration (rd) mouse., Ophthalmic Res. 29:290–297.
P.C. Huang, A.E. Gaitan, Y. Hao, R.M. Petters, and F. Wong, 1993, Cellular interactions implicated in the mechanism of photoreceptor degeneration in transgenic mice expressing a mutant rhodopsin gene, Proceedings of the National Academy of Sciences of the United States of America. 90(18):8484–8488.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Kluwer Academic / Plenum Publishers
About this chapter
Cite this chapter
Flannery, J.G. et al. (1999). Ribozyme-Mediated Gene Therapy for Autosomal Dominant Retinal Degeneration. In: Hollyfield, J.G., Anderson, R.E., LaVail, M.M. (eds) Retinal Degenerative Diseases and Experimental Therapy. Springer, Boston, MA. https://doi.org/10.1007/978-0-585-33172-0_27
Download citation
DOI: https://doi.org/10.1007/978-0-585-33172-0_27
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-46193-4
Online ISBN: 978-0-585-33172-0
eBook Packages: Springer Book Archive